They’re well aware that their fellow Germans might be repelled by the postcards: “Everyone’s frightened nowadays.” Earlier, ...
PrisMN Phase 2 trial of budoprutug in Primary Membranous Nephropathy (pMN) initiated Phase 1 trial of budoprutug subcutaneous formulation initiated, with initial data expected in H1 2026 Clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback